- Fletcher JW, Djulbegovic B, Soares HP, Siegel BA, Lowe VJ, Lyman GH, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008; 49(3):480-508.
- Johnson SA, Kumar A, Matasar MJ, Schöder H, Rademaker J. Imaging for staging and response assessment in lymphoma. Radiology. 2015; 276(2):323-38.
- Lin C, Itti E, Haioun C, Petegnief Y, Luciani A, Dupuis J, et al. Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma: SUV-based assessment versus visual analysis. J Nucl Med. 2007; 48(10):1626-32.
- Weber BWA, Petersen V, Schmidt B, Tyndale-hines L, Link T, Peschel C. Positron Emission Tomography in Non – Small-Cell Lung Cancer : Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use. J Clin Oncol.2003; 21(14): 2651-7.
- Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. Am J Roentgenol. 2010; 195(2):310-20.
- Benz MR, Evilevitch V, Allen-auerbach MS, Eilber FC, Phelps ME, Czernin J, et al. Treatment Monitoring by 18F-FDG PET / CT in Patients with Sarcomas : Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopatho- logically Responding and Nonresponding Tumors. J Nucl Med.2008; 49(7): 1038 -46.
- Lodge MA, Chaudhry MA, Wahl RL. Noise considerations for PET quantification using maximum and peak standardized uptake value. J Nucl Med. 2012; 53(7):1041-7.
- Soret M, Bacharach SL, Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med. 2007; 48(6):932-45.
- Nahmias C, Wahl LM. Reproducibility of standardized uptake value measurements determined by 18F-FDG PET in malignant tumors. J Nucl Med. 2008; 49(11):1804-8.
- Krak NC, Boellaard R, Hoekstra OS, Twisk JWR, Hoekstra CJ, Lammertsma AA. Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging. 2005; 32(3): 294-301.
- Beyer T, Czernin J, Freudenberg LS. Variations in clinical PET/CT operations: results of an international survey of active PET/CT users. J Nucl Med. 2011; 52(2): 303-10.
- Young H, Baum R, Cremerius U, Herholz K, Hoekstra O, Lammertsma AA, et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxy-glucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. Eur J Cancer. 1999; 35(13):1773-82.
- Nakamoto Y, Zasadny KR, Minn H, Wahl RL. Reproducibility of common semiquantitative parameters for evaluating lung cancer glucose metabolism with positron emission tomography using 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol. 2002; 4(2):171-8.
- Velasquez LM, Boellaard R, Kollia G, Hayes W, Hoekstra OS, Lammertsma AA, et al. Repeatability of 18F-FDG PET in a multicenter phase I study of patients with advanced gastrointestinal malignancies. J Nucl Med. 2009; 50(10):1646-54.
- Hashimoto N, Morita K, Tsutsui Y, Himuro K, Baba S, Sasaki M. Time-of-flight information improved the detectability of subcentimeter spheres using a clinical PET/CT scanner. J Nucl Med Technol. 2018; 46(3):268-73.
- Rahmim A, Qi J, Sossi V. Resolution modeling in PET imaging: Theory, practice, benefits, and pitfalls. Med Phys. 2013; 40(6):064301.
- Kidera D, Kihara K, Akamatsu G, Mikasa S, Taniguchi T, Tsutsui Y, et al. The edge artifact in the point-spread function-based PET reconstruction at different sphere-to-background ratios of radioactivity. Ann Nucl Med. 2016; 30(2):97-103.
- Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values. J Nucl Med. 2005; 46(3):424-8.
- Maebatake A, Morita K, Akamatsu G, Tsutsui Y, Himuro K, Baba S, et al. The influence of minimal misalignment on the repeatability of PET images examined by the repositioning of point sources. J Nucl Med Technol. 2019; 47(1):55-9.
- Fukukita H, Suzuki K, Matsumoto K, Terauchi T, Daisaki H, Ikari Y, et al. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: Synopsis of Version 2.0. Ann Nucl Med. 2014; 28(7): 693-705.
- Munk OL, Tolbod LP, Hansen SB, Bogsrud T V. Point-spread function reconstructed PET images of sub-centimeter lesions are not quantitative. EJNMMI Phys. 2017; 4(1):1–12.
- Rogasch JMM, Hofheinz F, Lougovski A, Furth C, Ruf J, Großer OS, et al. The influence of different signal-to-background ratios on spatial resolution and 18F-FDG-PET quanti-fication using point spread function and time-of-flight reconstruction. EJNMMI Phys. 2014; 1(1):1-16.
- Thielemans K, Asma E, Ahn S, Manjeshwar RM, Deller T, Ross SG, et al. Impact of PSF modelling on the convergence rate and edge behaviour of em images in PET. IEEE Nucl Sci Symp Conf Rec. 2010; 3267-72.
- Tong S, Alessio AM, Kinahan PE. Noise and signal properties in PSF-based fully 3D PET image reconstruction: An experimental evaluation. Phys Med Biol. 2010; 55(5): 1453-73.
- Morey AM, Noo F, Kadrmas DJ. Effect of using 2mm voxels on observer performance for PET lesion detection. IEEE Trans Nucl Sci. 2016; 63(3):1359-66.
- Akamatsu G, Mitsumoto K, Taniguchi T, Tsutsui Y, Baba S, Sasaki M. Influences of point-spread function and time-of-flight reconstructions on standardized uptake value of lymph node metastases in FDG-PET. Eur J Radiol. 2014; 83(1):226–30.
- Adler S, Seidel J, Choyke P, Knopp M V, Binzel K, Zhang J, et al. Minimum lesion detectability as a measure of PET system performance. EJNMMI Phys. 2017; 4:13.
- Boellaard R, Krak NC, Hoekstra OS, Lammertsma AA. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: A simulation study. J Nucl Med. 2004; 45(9): 1519-27.
- Koopman D, van Dalen JA, Lagerweij MCM, Arkies H, de Boer J, Oostdijk AHJ, et al. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel recon-structtions. J Nucl Med Technol. 2015; 43(1):21-7.
- Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009; 50(SUPPL. 1):122-50.
- Kinahan PE, Perlman ES, Sunderland JJ, Subramaniam R, Wollenweber SD, Turkington TG, et al. The QIBA profile for FDG PET/CT as an imaging biomarker measuring response to cancer therapy. Radiology. 2020; 294(2):647-57.
|